For a drugmaker advancing medicines through clinical trials, time is the enemy: the longer the process takes, the more costs ...

Shares of Moderna Inc. MRNA inched 0.55% higher to $53.09 Friday, on what proved to be an all-around mixed trading session ...

Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), ...

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

Anticipated earnings release is in 16 days. A total of 2 professional analysts have given their take on this stock in the ...

Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers’ 2024 Top Employers Survey for the tenth consecutive ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...